[TEVA] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
27-Jul-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 75.71%
YoY- -212.08%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 3,661,000 3,884,000 3,595,000 3,785,000 3,661,000 4,100,000 3,886,000 -3.90%
PBT -258,000 -1,100,000 166,000 -1,160,000 -971,000 -175,000 382,000 -
Tax -19,000 154,000 107,000 -900,000 2,000 -24,000 76,000 -
NP -205,000 -1,221,000 56,000 -232,000 -955,000 -159,000 292,000 -
Tax Rate - - -64.46% - - - -19.90% -
Total Cost 3,866,000 5,105,000 3,539,000 4,017,000 4,616,000 4,259,000 3,594,000 4.98%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -5.60 -31.44 1.56 -6.13 -26.09 -3.88 7.51 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.18 -1.10 0.05 -0.21 -0.86 -0.14 0.26 -
EPS Diluted -0.18 -1.10 0.05 -0.21 -0.86 -0.14 0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.